Patent Baristas

Pharma IQ put out it’s list of the Top Pharma Bloggers for 2013. These lists tend to be subjective and always leave off many great sites. But, these can be a good way to discover a blog you haven’t been following.  The only downside is that when you follow great blog’s like those by Kurt Karst […]

With four days left until BIO 2012 in Boston, EvaluatePharma’s World Preview 2018 warns of excessive R&D spending, but patent cliff may “liberate” drug companies.  EvaluatePharma released a report on the pharmaceutical industry entitled “World Preview 2018: Embracing the Patent Cliff,” whcih includes analysts’ forecasts on which companies and products will come out as winners […]

OK, maybe not explode but at least some terrible, Armageddon-like fate.  According to a study by the Federal Trade Commission, pharmaceutical companies are engaging in anti-competitive tactics of paying potential generic rivals to delay the introduction of lower-cost prescription drug alternatives.  The report summarizes data on patent settlements filed with the FTC and the Department […]

When: Tuesday, May 03 to Wednesday, May 04, 2011 Where: Marriott Downtown, New York City, NY What: American Conference Institute’s Paragraph IV Disputes conference is the undisputed source for Hatch-Waxman litigation strategies for brand-names and generics. This event — which is widely recognized for setting the standards for Paragraph IV litigation and which also serves […]

The University of Baltimore School of Law’s Intellectual Property Law Journal seeks articles for its Spring 2011 symposium issue.  The symposium’s theme is: “The Incentive to Invent: Intellectual Property Protection and the U.S. Biotechnology and Pharmaceutical Industries.” The symposium seeks to explore issues and trends related to the role which intellectual property plays in the […]

In a recent paper by Yali Friedman of the BiotechBlog, Yali looks at the growth of research capabilities in emerging economies such as India and China. With a substantial increase in the outsourcing of some of the more routine activities involved in pharmaceutical research and development (R&D), such as compound synthesis and preclinical toxicity tests, […]

Recently, the courts looked at the question of whether separate enantiomers can have “first commercial marketing or use” status for purposes of patent term extension under 35 U.S.C. § 156. The U.S. Patent and Trademark Office, after consulting with the FDA, had granted an extension for US Pat. No. 5,053,407, which is exclusively licensed to […]

The Pharmacy Technician Certification blog posted its round-up of the 50 Best Twitter Feeds for Pharma News.  While there is no shortage of feeds you can find in pharma, this list provides a breakdown of the best feeds in various categories. Best Pro Twitter Feeds for Pharma News include: Pharma Twits Café Pharma Fierce Pharma […]